A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
for Low-grade Glioma
14 locations incl. San Francisco
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All·Age: 6 Months - 25
Code: NCT04775485·Phase 2·Recruiting